Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Rocket Pharmaceuticals Q2 EPS $(0.83) Down From $(0.55) YoY

Rocket Pharmaceuticals Q2 EPS $(0.83) Down From $(0.55) YoY

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.

byMichael Horton

August 8, 2022

1 minute read

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.

Citigroup Maintains Neutral on Marsh & McLennan, Raises Price Target to $190

By Benzinga Newsdesk

February 1, 10:21 AM

Citigroup analyst Michael Ward maintains Marsh & McLennan (NYSE:MMC) with a Neutral and raises the price target from $185 to $190.

MMC

$1000 Invested In ConocoPhillips 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

October 20, 2:43 PM

ConocoPhillips (NYSE:COP) has outperformed the market over the past 5 years by 11.84% on an annualized basis producing an average annual return of 19.16%. Currently, ConocoPhillips has a market capitalization of $155.97 billion.

COP